Insiders · Profile

Giordano Christopher Thomas

CEO at TENAX THERAPEUTICS. Filing since 18 Nov 2025. CIK 0001871714

Company
Date
Role
Action
Shares
Amount
Of holding
15 Sep 2026
CEO
Bought
4,850
$8.84K
28.0%
11 Sep 2026
CEO
Bought
6,000
$11.25K
53.0%
20 Nov 2025
CEO
Bought
538
$4.08K
26.0%
19 Nov 2025
CEO
Bought
455
$3.42K
28.2%
18 Nov 2025
CEO
Bought
1,612
$12.50K
opened
5 decisions on file.